Data / Form D filings / OT Pharma Fund VIII, LLC
OT Pharma Fund VIII, LLC: Form D filing
OT Pharma Fund VIII, LLC, a company in Boston, MA, filed a Form D with the SEC in 2023. The latest, on July 10, 2023, reports $2.4 million sold of an offering with no set size to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 451 D STREET, SUITE 908, Boston, MA, 02210
- Phone
- (617) 459-3741
- Industry
- Other
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(c), Investment Company Act section 3(c), section 3(c)(1)
- SEC identifier (CIK)
- 1983872
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 10, 2023 | New notice | Indefinite | $2,400,000 | 10 | Jun 30, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nichola Eliovits | Executive Officer |
Other companies in Massachusetts that filed recently
- WEG Consolidated, LLC $675,460 · Oct 30, 2026
- Drowsy Digital, Inc. $37.7 million · Oct 29, 2026
- Netta Argamon SPV LLC $200,000 · Oct 23, 2026
- Crown Topco, LLC $8.3 million · Oct 19, 2026
- Curiosity Brewing Co LLC $245,000 · Oct 13, 2026
- POSEIDON'S FORGE, INC. $1.7 million · Oct 9, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in Massachusetts · All recent Other filings
Read from SEC EDGAR. Amount sold is what OT Pharma Fund VIII, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.